Induced pluripotent stem cells (iPSCs) have unlimited proliferative capacity and multi-lineage differentiation potential. Autologous iPSC-derived cells reduce the risk of immune rejection, making them promising resources for regenerative medicine. However, iPSCs derived using conventional methods often show heterogeneity and defects in differentiation potential in a subset of cells. To overcome these limitations, we developed a novel reprogramming strategy, termed the “4CL-primed” strategy, that incorporates a transient early-pluripotency (4CL) treatment during reprogramming. The 4CL-primed iPSCs retained the core characteristics of conventional iPSCs, including normal morphology, pluripotency marker expression, and karyotypic stability, while exhibiting enhanced mesodermal and endodermal differentiation capacity. Furthermore, the cells showed superior performance in directed pancreatic lineage differentiation, generating a higher proportion of pancreatic endocrine β-like cells. Collectively, the 4CL-primed strategy offers a more practical approach for mesodermal and endodermal differentiation research, particularly pancreatic lineage differentiation, thereby providing a more efficient source of pancreatic lineage cells for regenerative medicine and cell-based therapy.
Zhang, Mengna, Zheng, Ran, Wang, Yujiao et al. A novel strategy to generate human iPSCs with enhanced mesodermal and endodermal differentiation capacity. // Cell Regeneration. – 2026. – DOI: 10.1186/s13619-026-00306-9. – URL: https://www.biomedcentral.com/openurl?doi=10.1186/s13619-026-00306-9
Zhang, Mengna, Zheng, Ran, Wang, Yujiao, Wen, Junjie, Xu, Jingyu, Xiao, Dan, Cheng, Yanhong, Wang, Liang, Cao, Weifan, Gao, Yunfeng, Cai, & Cheguo (2026). A novel strategy to generate human iPSCs with enhanced mesodermal and endodermal differentiation capacity. Cell Regeneration. https://doi.org/10.1186/s13619-026-00306-9
Zhang, et al. “A novel strategy to generate human iPSCs with enhanced mesodermal and endodermal differentiation capacity.” Cell Regeneration, 2026. doi:10.1186/s13619-026-00306-9.
@article{Zhang2026,
title = {A novel strategy to generate human iPSCs with enhanced mesodermal and endodermal differentiation capacity},
author = {Zhang and Mengna and Zheng and Ran and Wang and Yujiao and Wen and Junjie and Xu and Jingyu and Xiao and Dan and Cheng and Yanhong and Wang and Liang and Cao and Weifan and Gao and Yunfeng and Cai and Cheguo},
journal = {Cell Regeneration},
year = {2026},
doi = {10.1186/s13619-026-00306-9},
url = {https://www.biomedcentral.com/openurl?doi=10.1186/s13619-026-00306-9}
}
Background Human liver organoids are useful for modeling steatotic liver injury and exploring disease-related mechanisms. This study examined the role of negative elongation factor E (NELFE) in metabolic dysfunction-associated steatotic...
Dysfunctional Epicardial adipose tissue (EAT), a specific beige/brown-like fat depot predominantly present in humans, is associated with coronary artery disease, atrial fibrillation and impaired systolic function. On the molecular...
Allometric growth is a key factor in understanding morphological development and biomass allocation in marine invertebrates. In crustaceans, growth is typically non-isometric, with mass scaling disproportionately with body size across...
The progression of malignancy depends entirely on profound restructuring of cells metabolic framework, allowing tumors to bypass physiological limitations while sustaining constant anabolic growth. Alteration of metabolic networks...
The discovery of induced pluripotent stem cells (iPSC) was met with optimism that this new technology would revolutionize how we model and treat human diseases. The last 20 years of research, however, has somewhat tempered the initial...